Michael Schomaker

17PUBLICATIONS
85CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsEpidemiological methodsMajor global burdens of diseaseHealth policy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.

|Dec 03, 2024
Determining Targets for Antiretroviral Drug Concentrations: A Causal Framework Illustrated With Pediatric Efavirenz Data From the CHAPAS-3 Trial.

Michael Schomaker, Paolo Denti, Andrzej Bienczak

|Nov 18, 2024
Recoverability of causal effects under presence of missing data: a longitudinal case study.

Anastasiia Holovchak, Helen McIlleron, Paolo Denti

|Jul 04, 2024
Correcting mortality estimates among children and youth on antiretroviral therapy in southern Africa: A comparative analysis between a multi-country tracing study and linkage to a health information exchange.

Patience Nyakato, Michael Schomaker, Andrew Boulle

|Jan 06, 2023
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study.

Igor Stojkov, Annette Conrads-Frank, Ursula Rochau

|Apr 30, 2021
Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities-An Agent-Based Modeling Evaluation.

Beate Jahn, Gaby Sroczynski, Martin Bicher

Pageof 3

Frequent Collaborators

2 joint publications

Miguel Angel Luque-Fernandez

2 joint publications

Igor Stojkov

2 joint publications

Johannes Laimer

2 joint publications

Uwe Siebert